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Gamma interferon (IFN-) plays a critical role in the early eradication of Anaplasma phagocytophilum.
However, the mechanisms that regulate IFN- production upon infection remain poorly understood. Here we
show that c-Jun NH2-terminal kinase 2 (JNK2) inhibits IFN- production during A. phagocytophilum infection.
jnk2-null mice were more refractory to infection with A. phagocytophilum and produced increased levels of
IFN- after challenge with the pathogen. The resistance of jnk2-null mice to A. phagocytophilum infection was
due to elevated levels of IFN- secreted by conventional and natural killer (NK) T cells. The administration
of -galactosylceramide, a strong NK T-cell agonist, increased IFN- release and protected mice from A.
phagocytophilum, further demonstrating the inhibitory effect of JNK2 on IFN- production. Collectively, these
findings provide strong evidence that JNK2 is an important regulatory protein for IFN- secretion upon
challenge with A. phagocytophilum.
Anaplasma phagocytophilum infection causes human granu-
locytic anaplasmosis (HGA), and the organism can infect neu-
trophils, neutrophil precursors, and endothelial cells (13, 26).
HGA is often asymptomatic or mild, with fevers, headache,
myalgia, thrombocytopenia, or neutropenia. Severe complica-
tions may include septic shock, respiratory distress syndrome,
rhabdomyolysis, myocarditis, acute renal failure, hemorrhage,
neuropathy, hepatitis, and opportunistic infections (2, 12, 13).
The cytokine gamma interferon (IFN-) contributes to the
eradication of A. phagocytophilum (1, 21, 24, 30, 31, 38). IFN-
gene-null mice have a markedly elevated A. phagocytophilum
load compared to that of wild-type mice during the early phase
of infection. The mechanisms, however, that regulate IFN-
production upon infection remain poorly understood. We hy-
pothesized that the c-Jun NH2-terminal kinase (JNK) pathway
could be important for the regulation of IFN- production
because the JNK pathway is important for T helper 1 differ-
entiation (11, 33, 40). We found that c-Jun NH2-terminal ki-
nase 2 (JNK2) inhibited IFN- production during A. phagocy-
tophilum infection. This study represents the first step toward
identifying inhibitory proteins that modulate IFN- secretion
upon A. phagocytophilum infection.
MATERIALS AND METHODS
Bacterial strain, lipid antigens, and mouse strains. The NCH-1 isolate of A.
phagocytophilum, recovered from a patient with HGA, was used throughout
these studies (36). Sphingomonas sp. lipids PBS 57 and PBS 74 were described
previously (23). -Galactosylceramide (-GalCer) and globotrihexosylceramide
(GB3) were purchased from Alexis Biochemicals (Switzerland). C57BL/6,
BALB/c, cd1d-null, and rag1-null mice were purchased from Jackson Laboratory
(Bar Harbor, ME). Cd1d-null mice were backcrossed onto the BALB/c back-
ground for at least 10 generations. jnk2-null mice, described previously (40), were
backcrossed onto the C57BL/6 background for at least six generations. All mice
used for in vivo infection were 4 to 12 weeks of age, sex matched, and maintained
under specific pathogen-free conditions at Yale University School of Medicine.
The experiments were done in accordance with the Yale University institutional
animal care and university committee guidelines.
A. phagocytophilum infection and detection methods. A. phagocytophilum was
cultured in HL-60 cells (catalog no. 240-CCL; American Type Culture Collec-
tion, Manassas, VA) grown in Iscove’s modified Dulbecco’s medium (Gibco
BRL/Life Technologies, Grand Island, NY) supplemented with 20% fetal calf
serum at 37°C with 5% CO2 (19). Cells were sustained with medium replacement
once a week. A. phagocytophilum-infected cells were maintained as described
previously with an equal volume of uninfected cells added to infected cells and
diluted 1:5 with fresh medium (37). Cell-free A. phagocytophilum was collected
from 95% A. phagocytophilum-infected HL-60 cells. Infected cells were centri-
fuged for 10 min at 4,000 g. The cell pellet was resuspended in culture medium
and lysed by six passages through a 25-gauge needle, followed by six passages
through a 27-gauge needle. The cell lysate was centrifuged at 1,200 g for 3 min,
and the supernatant was used for infection. A. phagocytophilum was separated
from host cells, heat killed for 45 min at 65C, and used for stimulation assays.
Blood from rag1-null mice chronically infected with the A. phagocytophilum
NCH-1 strain (20 to 25% neutrophil infection) was used to inoculate inbred
immunocompetent and gene-deficient mice. A. phagocytophilum infection in
rag1-null mice was determined by using the percentage of morulae-containing
granulocytes (A. phagocytophilum aggregates) examined in a peripheral blood
smear. Slides were stained with Diff-Quick (Baxter Healthcare Corporation,
Miami, FL) and examined for morulae by using light microscopy (1).
Cytokines and antibodies. Recombinant murine interleukin-12 (IL-12)p40/p70
and IFN- were purchased from BD Pharmingen (San Diego, CA). IL-18 and
anti-IL-18 antibodies for enzyme-linked immunosorbent assay (ELISA) were
purchased from MBL (Woburn, MA). Anti-mouse monoclonal antibodies for
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cytokine and surface labeling were purchased from BD Pharmingen, as follows:
purified anti-IL-12p40/p70 (C15.6, rat immunoglobulin G1 [IgG1]); purified anti-
IFN- (R4-6A2, rat IgG1); fluorescein isothiocyanate-conjugated anti-CD69
(Hi.2F3, Armenian hamster IgG1); phycoerythrin-Cy5 (PE-Cy5)-conjugated an-
ti-CD4 (H129.19, rat IgG2a), PE-Cy7-conjugated anti-CD8 (SK1, mouse IgG1);
PE-conjugated anti-IFN- (XMG1.2, rat IgG1); PE-Cy7-conjugated anti-IFN-
(XMG1.2, rat IgG1); and fluorescein isothiocyanate-conjugated anti-CD8 (SK1,
mouse IgG1).
T-cell hybridoma assay. The NK T hybridoma cell line V14-J18 DN32.D3
was described previously (25). DN32.D3 cells (2.5  105 cells) were cocultivated
with 2.5  105 cells from either wild-type or jnk2-null bone marrow-derived
dendritic cells (BMDC) as previously described (25) in the presence of stimu-
lants for 18 h. IL-2 release in cultured supernatants was measured using CTLL-2
indicator cells (3). BMDC were prepared from bone marrow cells that were
collected by removing the femur bones of mice, cutting off the ends of the bones,
and flushing out the bone marrow with RPMI 1640 medium injected with a
syringe. The pooled cells were harvested by centrifugation at 1,600 g for 10 min
and resuspended in 1 ml of red blood cell lysis buffer (Sigma, St Louis, MO) for
5 min at room temperature. These cells were washed in RPMI 1640 medium and
cultured in RPMI 1640 medium containing 500 U of murine recombinant gran-
ulocyte-macrophage colony-stimulating factor (mrGM-CSF)/ml for 6 days prior
to analysis. BMDC were collected in ice-cold phosphate-buffered saline and used
for T-cell hybridoma assays.
A. phagocytophilum restimulation assays and flow cytometry analysis. Wild-
type and jnk2-null mice were euthanized, and spleens and livers were removed 6
days post-A. phagocytophilum infection. Following spleen removal, the spleno-
cytes from wild-type and jnk2-null mice were restimulated with A. phagocytophi-
lum for 18 h and surface stained with anti-CD4 and anti-CD8. For the intracel-
lular staining, brefeldin A was added 3 h before harvesting. For liver cell
isolation, age- and sex-matched C57BL/6 and jnk2-null mouse livers were per-
fused, and the differential centrifugation method using colloidal silica particles
coated with polyvinylpyrrolidone (Percoll) was used to isolate mononuclear cells
(7). CD1d--GalCer tetramers were generated and used as described previously
(5). Flow cytometry was performed as described previously (25) using a FACS-
calibur flow cytometer (BD Biosciences). Data were analyzed using Cell Quest
Pro software (BD Biosciences).
Determination of cytokine levels in infected mice. Retroorbital bleeding of the
wild-type and the gene-deficient mice was performed at indicated time points.
Sera from animals in each group were pooled, and cytokine levels were assessed
using sandwich ELISA.
Quantification of A. phagocytophilum in the peripheral blood of mice. To
quantify the A. phagocytophilum load in the peripheral blood, 100 l of antico-
agulated peripheral blood from gene-deficient mice and from wild-type mice was
incubated with 900 l of erythrocyte lysis buffer (Sigma, St. Louis, MO) at room
temperature for 20 min. DNA was extracted using a DNeasy tissue kit (QIA-
GEN, Valencia, CA), according to the manufacturer’s recommendation. DNA
samples were mixed with an iQ SYBR green I supermix (Bio-Rad, Hercules, CA)
in an iCycler thermal cycler (Bio-Rad, Hercules, CA). Quantitative reverse
transcription (qRT)-PCR conditions were performed as previously described
(29). DNA levels were normalized to that of the mouse -actin gene (GenBank
accession number X03672). The A. phagocytophilum 16S rRNA (GenBank ac-
cession number M73224) gene was then quantified.
Statistical analysis. P values were calculated by using experimental and con-
trol data, using the nonpaired Student t test. Statistical significance was set at a
P value of 0.05.
RESULTS
JNK2 inhibits IFN- production and promotes resistance to
A. phagocytophilum infection. To define the precise role of
JNK2 in IFN- production during A. phagocytophilum infec-
tion, we stimulated wild-type and jnk2-null spleen cells with
heat-killed A. phagocytophilum, a potent IFN- inducer. We
noticed increased IFN- release from jnk2-null cells upon A.
phagocytophilum stimulation compared to that from control
cells (Fig. 1A). IL-4 secretion was not evident upon A. phago-
cytophilum stimulation in both the wild-type and the jnk2-null
cells, suggesting that A. phagocytophilum is a strict Th1 inducer
(Fig. 1B). We then infected jnk2-null mice with A. phagocyto-
philum to determine whether JNK2 plays an inhibitory role in
IFN- production in vivo. The levels of IFN- in murine pe-
ripheral blood increased dramatically after 3 to 4 days follow-
ing infection and returned to baseline levels at day 8 (Fig. 1C).
IFN- secretion was twofold higher in jnk2-null mice at days 3
and 4 than in wild-type mice (Fig. 1C).
We then investigated whether IL-12 and IL-18 contribute to
IFN- secretion upon A. phagocytophilum infection. IL-12 and
IL-18 have a synergistic effect on IFN- secretion (10, 18).
Furthermore, both cytokines have been shown to be important
for the eradication of A. phagocytophilum from the host (30,
31). IL-18 secretion was significantly higher in jnk2-null mice,
suggesting that there is an association with IFN- production
in vivo (Fig. 1D). IL-18, however, may also play a role in A.
phagocytophilum infection that is IFN- independent, because
IL-18 was also produced after IFN- production and returned
to baseline levels (between days 8 and 12). On the other hand,
IL-12 levels in the peripheral blood of jnk2-null mice were
slightly reduced compared to that of wild-type mice (Fig. 1E).
IFN- plays an important role in the host’s defense against
A. phagocytophilum infection (1, 21, 24, 30, 31, 38). Therefore,
we determined the pathogen’s burden in wild-type and jnk2-
null mice after infection. A. phagocytophilum infection in the
peripheral blood of jnk2-null mice was decreased 10- to 16-fold
at days 4 and 8 postinfection (Fig. 1F). We did not observe any
differences between the bacterial loads of wild-type and jnk2-
null mice at day 10 when both mouse groups were clearing the
infection. Taken together, our results suggest that JNK2 has an
inhibitory role in IFN- production upon A. phagocytophilum
stimulation.
JNK2 ablation results in greater IFN- production by CD4
and CD8 T cells upon A. phagocytophilum stimulation. In-
creased levels of IFN- in the sera of jnk2-null mice may be
due to increased IFN- production by T cells. To determine
whether JNK2 regulates the production of IFN- in CD4 and
CD8 T cells, intracellular staining was used. We performed
our analysis with CD4 and CD8 T cells at day 6 postinfec-
tion because the IFN- response was more likely to be trig-
gered by CD4 and CD8 T cells at this stage. Overall, CD4
and CD8 T cells produced low levels of IFN- upon infection,
and nonrestimulated CD4 and CD8 T cells from wild-type and
jnk2-null mice had only minimal IFN- production (Fig. 2A and
B). However, IFN- levels were twofold higher in restimulated
CD4 and CD8 T cells from jnk2-null mice than in those
from wild-type animals. Taken together, these results strongly
suggest that JNK2 inhibits IFN- production by CD4 and
CD8 T cells upon A. phagocytophilum stimulation.
JNK2 inhibits IFN- production by NK T cells. We exam-
ined the role of natural killer (NK) T cells in immunity to A.
phagocytophilum infection because previous studies have dem-
onstrated that CD1d-restricted NK T cells contribute to the
defense against Ehrlichia muris (25), an organism closely re-
lated to A. phagocytophilum. Choi et al. (8) have also suggested
that NK T cells are activated during infection. We first assessed
the expression of JNK2 in tetramer-sorted CD1d-restricted
NK T cells from heterozygotes jnk2 and jnk2-null mice cocul-
tivated with wild-type BMDC stimulated with heat-killed A.
phagocytophilum. The analysis revealed that activated CD1d-
restricted NK T cells from heterozygous jnk2 mice were able to
phosphorylate JNK (Fig. 3A). On the other hand, jnk2-null
mice did not show any JNK phosphorylation when NK T cells
VOL. 76, 2008 JNK2 INHIBITS IFN- DURING ANAPLASMA INFECTION 309
 o
n
 M
ay 31, 2016 by UNIV O
F M
ASS M
ED SCH
http://iai.asm
.org/
D
ow
nloaded from
 
were activated. Nonphosphorylated levels of JNK proteins
were expressed at levels that were comparable in both groups
of mice. These results strongly suggest that JNK proteins play
a critical role in signaling processes during NK T-cell activa-
tion.
We then evaluated the NK T-cell response to A. phagocyto-
philum infection by using mice that do not carry functional
CD1d-restricted NK T cells. Cd1d-null mice had a higher
pathogen load at day 2 than the wild-type animals (Fig. 3B),
which is consistent with an early role of NK T cells in A.
phagocytophilum immunity. The reduced capacity to eradicate
A. phagocytophilum correlated with lower levels of IFN- in the
FIG. 1. JNK2 deficiency increases IFN- levels in peripheral blood and decreases murine susceptibility to A. phagocytophilum infection.
Wild-type and jnk2-null mice were euthanized, and spleens were removed 6 days post-A. phagocytophilum infection. Wild-type (n	 5) and jnk2-null
(n 	 5) mouse spleen cells (106 cells) were restimulated with heat-killed A. phagocytophilum (at multiplicities of infection of 100, 10, and 1
PFU/cell) for 18 h, and levels of IFN- (A) and IL-4 (B) were measured by ELISA. Serum concentrations of (C) IFN-, (D) IL-18, and
(E) IL-12p40/p70 were measured by ELISA in wild-type and jnk2-null mice infected with A. phagocytophilum (n	 6 per group). (F) Wild-type (n	
10) and jnk2-null (n 	 11) mice were infected with A. phagocytophilum, and the bacterial load was measured in peripheral blood using qRT-PCR.
Experiments were repeated twice, and the results for one representative experiment are shown. Data represent the means 
 standard deviations.
The asterisks denote statistical significance. Statistical significance was calculated using the unpaired Student’s t test (P  0.05).
310 PEDRA ET AL. INFECT. IMMUN.
 o
n
 M
ay 31, 2016 by UNIV O
F M
ASS M
ED SCH
http://iai.asm
.org/
D
ow
nloaded from
 
peripheral blood of cd1d-null mice (Fig. 3C). We did not de-
tect differences in IFN- secretion between the wild-type and
the cd1d-null mice at days 5 and 8, which was consistent with
similar A. phagocytophilum loads in the peripheral blood sam-
ples of both mouse groups (Fig. 3B).
To further support the role of NK T cells in A. phagocyto-
philum clearance, the NK T hybridoma cell line DN32.D3 was
cocultivated with BMDC from heterozygote and cd1d-null
mice in the presence of heat-killed A. phagocytophilum. The
cd1d-null cell culture showed reduced levels of IL-2 after A.
phagocytophilum stimulation (Fig. 3D). Similar results were
obtained after the culture was stimulated with the NK T-cell
agonist -GalCer. These results obtained with BALB/c cd1d-
null mice show that NK T cells play a direct role in the early
control of the A. phagocytophilum burden.
We then examined whether in vivo stimulation with -Gal-
Cer would promote enhanced IFN- production in jnk2-null
mice. -GalCer has a potent stimulatory effect on NK T cells
FIG. 2. JNK2 negatively regulates IFN- production in CD4 and CD8 T cells after A. phagocytophilum restimulation. Wild-type and
jnk2-null mice (n	 6 per group) were euthanized, and spleens were removed 6 days post-A. phagocytophilum infection. Splenocytes (5  106 cells)
from wild-type and jnk2-null mice were cultured ex vivo for 18 h in the presence or absence (n 	 3 per group) of heat-killed A. phagocytophilum
(107 bacterial cells), and CD4 and CD8 T-cell production of intracellular IFN- was determined. Numbers in the upper-right quadrants are the
percentages of IFN--producing cells in (A) CD4 and (B) CD8 T cells. The signs () and () indicate the presence or absence of heat-killed
A. phagocytophilum. Data represent the means 
 standard deviations. The asterisks denote statistical significance. Statistical significance was
calculated using the unpaired Student’s t test (P  0.05).
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and has been used extensively as an NK T-cell stimulant in vivo
(15, 27, 35). -GalCer stimulation increased IFN- in the pe-
ripheral blood samples of jnk2-null mice at 24 h postinjection
(Fig. 4A). On the other hand, IL-4 production peaked at 2 h
postinjection in the wild-type genotype and was increased com-
pared to that in the jnk2-null mice (Fig. 4B). The molecule
GB3 was used as a negative control and did not show any
stimulatory effect postinjection. Thus, our results suggest that
JNK2 inhibits IFN- production by NK T cells.
Next, we prepared BMDM from wild-type and jnk2-null
FIG. 3. NK T cells play an important role in early A. phagocytophilum immunity. (A) Tetramer-sorted CD1d-restricted NK T cells (2.5  105
cells) from heterozygous jnk2 (n 	 4) and jnk2-null (n 	 4) mice were cocultivated with wild-type BMDC (2.5  105 cells) in the presence of
heat-killed A. phagocytophilum (at a multiplicity of infection of 100 PFU/cell) for 20 min. Cells were then lysed, and proteins (20 g) were
normalized and subjected to immunoblotting using the phospho (Thr-183/Tyr-185)-JNK and total JNK antibodies as indicated. (B) Wild-type and
cd1d-null mice were infected with A. phagocytophilum, and the bacterial load was measured in peripheral blood using qRT-PCR. (C) Serum
concentrations of IFN- in 6- to 12-week-old wild-type (n 	 5) and cd1d-null (n 	 5) mice were measured by ELISA at the indicated time points.
(D) The IL-2 response of the V14 NK T hybridoma DN32.D3 (2.5 105 cells) cell line cocultivated with heterozygous cd1d or cd1d-null dendritic
cells (2.5  105 cells) in the presence of 107 heat-killed A. phagocytophilum or -GalCer (100 ng/ml) cells for 18 h is indicated; NS, no A.
phagocytophilum. Data represent the means 
 standard deviations. Statistical significance was calculated using the unpaired Student’s t test (P 
0.05).
FIG. 4. IFN- response in jnk2-null mice is increased upon glycolipid stimulation. Wild-type (n 	 10) and jnk2-null (n 	 10) mice were
stimulated with an intraperitoneal injection of -GalCer (250 ng/mouse) or GB3 (250 ng/mouse), and levels of (A) IFN- and (B) IL-4 were
determined at the indicated time points, using ELISA. Data represent the means
 standard deviations. Statistical significance was calculated using
the unpaired Student’s t test (P  0.05).
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mice to determine whether the increased IFN- production by
NK T cells observed for jnk2-null cells was due to enhanced
lipid presentation. To test this hypothesis, we cocultivated the
NK T hybridoma cell line DN32.D3 with BMDM from either
the wild-type or the jnk2-null mice for 18 h in the presence of
the NK T agonists PBS 57 and PBS 74 and measured IL-2
poststimulation. We did not detect differences between levels
of IL-2 secretion by the NK T hybridoma cell line from either
the wild-type or the jnk2-null cells, suggesting that JNK2 does
not play a role in glycolipid presentation upon stimulation by
BDMC (Fig. 5A and B). Similar results were obtained after
stimulation with A. phagocytophilum (Fig. 5C). Taking these
FIG. 5. JNK2 does not alter glycolipid presentation upon stimulation. BMDM (2.5  105) from wild-type (n 	 5) and jnk2-null (n 	 5) mice
were cocultivated with the V14 NK T hybridoma DN32.D3 cell line (2.5  105 cells) in the presence of different concentrations of the NK T-cell
agonists (A) PBS 57 and (B) PBS 74 and (C) heat-killed A. phagocytophilum (at multiplicities of infection from 100 to 1 PFU/cell) for 18 h, and
the levels of the cytokine IL-2 were measured. The results of one representative experiment are shown. Data represent the means 
 standard
deviations.
FIG. 6. JNK2 ablation increases NK T-cell-derived IFN- production in jnk2-null mice after A. phagocytophilum restimulation. (A) Wild-type
and jnk2-null mice were euthanized, and liver cells were removed 6 days post-A. phagocytophilum infection. Liver cells (106 cells) from wild-type
(n 	 16) and jnk2-null (n 	 16) mice were restimulated with 107 heat-killed A. phagocytophilum for 18 h, and mouse mononuclear liver cells were
stained (tetramer and CD8). The percentage of cells in the V14 NK T-cell gate is indicated. APC, antigen-presenting cells. (B) V14 NK T
restimulated liver cells from wild-type and jnk2-null mice were stained (tetramer CD69), and the levels of IFN- were determined. The results
of one representative experiment are shown. Data represent the means 
 standard deviations. Statistical significance was calculated using the
unpaired Student’s t test (P  0.05). FITC, fluorescein isothiocyanate.
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findings together, we conclude that JNK2 directly controls
IFN- production mediated by NK T cells, since lipid presen-
tation is not affected.
A. phagocytophilum stimulation promotes increased IFN- pro-
duction by CD1d-restricted NK T cells from jnk2-null mice. We
used A. phagocytophilum to investigate whether JNK2 has a re-
pressive role in IFN- production mediated by CD1d-restricted
NK T cells. Wild-type and jnk2-null mice were infected with A.
phagocytophilum for 6 days, and mononuclear liver cells were
harvested and restimulated for 18 h.
It has been recently demonstrated that activated NK T cells
down-regulate the V14 NK T receptor after antigen stimula-
tion and that the effector functions of activated V14 NK T
cells, such as cytokine production, remain intact (16, 39). We
tested A. phagocytophilum reactivity to the V14 invariant NK
T-cell receptor using -GalCer-CD1d tetramers. We noticed a
twofold down-regulation of the V14 NK T receptor from
jnk2-null cells after A. phagocytophilum restimulation, which
suggested enhanced NK T-cell activation from these cells (Fig.
6A). Indeed, increased activation of NK T cells from jnk2-null
mice was directly correlated with higher IFN- production
(Fig. 6B). Collectively, our data demonstrate that JNK2 has an
inhibitory role in IFN- production mediated by CD1d-re-
stricted NK T cells.
Enhanced clearance of A. phagocytophilum by stimulated NK
T cells. We reasoned that the activation of CD1d-restricted
NK T cells could facilitate A. phagocytophilum clearance from
the host. This hypothesis was supported by two main findings:
(i) the clearance of the bacterium from cd1d-null mice was
decreased at day 2 postinfection, and (ii) strong evidence in-
dicated that NK T cells participate in A. phagocytophilum im-
munity. We therefore determined whether the activation of
NK T cells by the CD1d-restricted lipid -GalCer could result
in the faster elimination of A. phagocytophilum. Wild-type and
jnk2-null mice were given an intraperitoneal injection of
-GalCer and GB3, followed by infection with A. phagocyto-
philum 24 h later. GB3 was used as a negative control. We
chose to infect mice with A. phagocytophilum 24 h postinjection
because IFN- release peaks at 1 day poststimulation, as dem-
onstrated previously (Fig. 4).
We compared the bacterial load and the level of IFN-
release as a measure of protection against A. phagocytophilum
infection. Overall, both the wild-type and the jnk2-null mice
injected with GB3 showed more-than 1,000-fold more bacteria
in the peripheral blood compared to mice that received the
-GalCer injection treatments at day 2 postinfection (Fig. 7A).
The protective effect of -GalCer during A. phagocytophilum
infection decreased considerably at days 5 and 7. Similar bac-
terial loads among all treatment groups were observed at day
9 postinfection. The effect of -GalCer injection in jnk2-null
mice was more robust than in wild-type mice. Wild-type mice
injected with -GalCer carried 28- and 5.7-fold fewer bacteria
at days 5 and 7, respectively, than those receiving the GB3
treatment. On the other hand, jnk2-null mice injected with
-GalCer carried 1,000- and 18-fold fewer bacteria at days 5
and 7, respectively, than the GB3-treated mice. Decreased
levels of bacteria in the peripheral blood of wild-type and
jnk2-null mice injected with -GalCer were correlated with
higher levels of IFN- release (Fig. 7B). As expected, jnk2-null
mice injected with -GalCer presented a robust IFN- re-
sponse at 24 h postinjection. Surprisingly, the kinetics of IFN-
release was more delayed in wild-type mice injected with
-GalCer. Wild-type mice injected with -GalCer only showed
a great IFN- response 2 days postinfection when they encoun-
tered A. phagocytophilum. Taken together, these observations
suggest that JNK2 inhibits NK T-mediated IFN- production
upon A. phagocytophilum infection.
DISCUSSION
We describe evidence showing that JNK2 directly inhibits
IFN- production, mediated by conventional and NK T cells
upon A. phagocytophilum stimulation. These results are in dis-
agreement with a previous observation (40), which indicated
that the differentiation of precursor CD4 T cells into effector
Th1 cells was impaired in jnk2-null mice. We suggest that
opposite phenotypes may occur when different stimulants are
used to study the IFN- response in jnk2-null mice. Yang et al.
(40) used the concanavalin A model to understand the role of
JNK2 in Th1 differentiation, while we used A. phagocytophilum
to decipher how JNK2 regulates IFN- response upon infec-
tion.
A. phagocytophilum, Ehrlichia, and Sphingomonas are gram-
FIG. 7. -GalCer-injected mice are protected against A. phagocy-
tophilum infection. Heterozygous jnk2 (n 	 5) and jnk2-null (n 	 7)
mice were challenged with live A. phagocytophilum 24 h after receiving
intraperitoneal injections of -GalCer (200 ng per mouse). Heterozy-
gous jnk2 (n 	 4) and jnk2-null (n 	 5) mice were injected with GB3
(200 ng per mouse) and used as a negative control. (A) The relative
bacterial load differences between the blood of gene-sufficient mice
and that of gene-deficient mice were calculated by normalizing the
bacterial copy numbers of jnk2-null (-GalCer injected) mice to 1,
compared to those of mice receiving other treatments. (B) Pooled
serum concentrations of IFN- were measured by ELISA at the indi-
cated times. Data represent the means 
 standard deviations. ND, no
relative bacterial load difference in the blood of infected mice.
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negative bacteria that belong to the Alphaproteobacteria and
constitute one of the most ubiquitous classes of bacteria on
earth (4). Therefore, we decided to investigate whether A.
phagocytophilum has the capacity to induce IFN- production
mediated by CD1d-restricted NK T cells. Our results show that
cd1d-null mice have an impaired capacity to clear A. phagocy-
tophilum during the early phase of infection, which correlated
with lower levels of IFN- in the peripheral blood of cd1d-null
mice.
-GalCer tetramers demonstrated that A. phagocytophilum
has the capacity to stimulate CD1d-restricted NK T cells. In-
deed, our report of experiments with livers from wild-type and
jnk2-null mice shows that NK T cells from jnk2-null mice
down-regulate the T-cell receptor after A. phagocytophilum
restimulation. The decreased number of CD1d-tetramer-reac-
tive T cells may likely correspond to an enhanced NK T-cell
response from jnk2-null mice to A. phagocytophilum. De-
creased numbers of tetramer-positive CD1d-restricted NK T
cells had an inverse correlation with IFN- production. NK
T-cell receptor down-regulation as a feature of NK T-cell ac-
tivation has been suggested in several models, including A.
phagocytophilum, Listeria spp., Salmonella spp., and Toxo-
plasma gondii (6, 8, 9, 32, 34). However, it is also possible that
the NK T-cell receptor down-regulation in our studies could be
a consequence of T-cell receptor stimulation via activated cell
death (14, 17, 22). Further experimentation needs to be done
to determine the cause of NK T-cell receptor down-regulation
upon A. phagocytophilum infection.
We applied three different approaches to determine the
inhibitory role of JNK2 in NK T-cell function upon A. phago-
cytophilum infection. First, we found that IFN- production is
increased in jnk2-null mice upon stimulation with NK T-cell
agonists. Second, we determined that the enhanced NK T-cell
response from jnk2-null mice upon A. phagocytophilum infec-
tion is not due to increased glycolipid presentation by dendritic
cells. Third, we injected wild-type and jnk2-null mice with
-GalCer and observed a strong protective effect at day 2
postinfection. The injection of NK T agonists (e.g., -GalCer)
therefore could theoretically be used as a vaccine for therapy
against A. phagocytophilum infection. However, the design of
NK T-cell therapies against HGA must be applied with cau-
tion. NK T cells may function as a double-edged sword: acti-
vated NK T cells may aggravate the symptoms of human
anaplasmosis as opposed to ameliorating the disease (20, 28).
To summarize, our data clearly indicate that JNK2 has a re-
pressive role in IFN- production mediated by conventional
and NK T cells upon A. phagocytophilum infection. The knowl-
edge provided herein should permit a better understanding of
A. phagocytophilum immunity and contribute to the develop-
ment of prophylactic measures that thwart the spread of HGA.
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